2 studies found for:    19636002 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting Study of Continuous Dosing of Sunitinib in Non GIST Sarcomas With Concomitant Radiotherapy
Condition: Non GIST Sarcomas
Intervention: Drug: sunitinib
2 Active, not recruiting Capecitabine, Bevacizumab, and Radiation Therapy Followed By Gemcitabine and Bevacizumab in Treating Patients With Locally Advanced Pancreatic Cancer That Cannot Be Removed By Surgery
Conditions: Adenocarcinoma of the Pancreas;   Stage II Pancreatic Cancer;   Stage III Pancreatic Cancer
Interventions: Drug: capecitabine;   Radiation: radiation therapy;   Biological: bevacizumab;   Procedure: therapeutic conventional surgery;   Drug: gemcitabine hydrochloride

Indicates status has not been verified in more than two years